| Peter R Holbrook, MD | |
|
111 Michigan Ave Nw, Washington, DC 20010-2978 | |
| (202) 884-3256 | |
| (202) 884-5988 |
| Full Name | Peter R Holbrook |
|---|---|
| Gender | Male |
| Speciality | Pediatrics - Pediatric Critical Care Medicine |
| Location | 111 Michigan Ave Nw, Washington, District Of Columbia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043240674 | NPI | - | NPPES |
| 0174 | Other | DC | CAREFIRST |
| 6727841 | Medicaid | VA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2080P0203X | Pediatrics - Pediatric Critical Care Medicine | MD7963 (District Of Columbia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Peter R Holbrook, MD 111 Michigan Ave Nw, Washington, DC 20010-2978 Ph: (202) 884-3256 | Peter R Holbrook, MD 111 Michigan Ave Nw, Washington, DC 20010-2978 Ph: (202) 884-3256 |
News Archive
Boston Medical Center pediatricians Laura Johnson, MD, MPH, Jenny Radesky, MD, and Barry Zuckerman, MD, the Joel and Barbara Alpert Professor of Pediatrics at Boston University School of Medicine, have published a paper in the current issue of the journal Pediatrics that addresses how understanding the origins and goals of parenting behaviors can help pediatricians strengthen relationships with families, demonstrate cultural sensitivity, and more effectively offer guidance on the challenges of childrearing.
The sooner people with diabetes start taking metformin, the longer the drug remains effective, according to a Kaiser Permanente study published in the March issue of Diabetes Care, a journal of the American Diabetes Association.
Pharmaceutical company, Merck Sharp & Dohme has announced an immediate voluntary world-wide withdrawal of the drug, Vioxx (rofecoxib), commonly used for patients with rheumatoid or osteoarthritis.
Laureate Pharma, Inc., a full-service biopharmaceutical development and protein production company specializing in the development and GMP manufacture of monoclonal antibodies, fusion proteins and other therapeutic protein products, and Iconic Therapeutics, a company focused on the development of treatments for wet adult macular degeneration (wet AMD) and other ophthalmic diseases, today announced the completion of the manufacture of the first GMP lot of hI-con1(TM) recombinant Fc-Factor VII fusion protein.
The restrictive use of chloride in intravenous fluids reduces the risk for acute kidney injury and renal replacement therapy, research shows.
› Verified 4 days ago
Dr. Talita Michelle Jordan, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 111 Michigan Ave Nw, Washington, DC 20010 Phone: 202-476-5000 | |
Yue-hin Loke, MD Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 111 Michigan Ave Nw, W3.5, 600, Washington, DC 20010 Phone: 202-476-3670 | |
Elshadey Yayehyerade Bekele, Pediatrics Medicare: Medicare Enrolled Practice Location: 111 Michigan Ave Nw, Washington, DC 20010 Phone: 301-565-4279 | |
Jia Liu, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 111 Michigan Ave Nw, Washington, DC 20010 Phone: 202-476-5000 | |
Dr. Charles John Billington Jr., MDPHD Pediatrics Medicare: Medicare Enrolled Practice Location: 111 Michigan Ave Nw, W3.5, 600, Washington, DC 20010 Phone: 202-476-3670 Fax: 202-476-4741 | |
Dr. Joy Marie Morgan, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 111 Michigan Ave Nw, Washington, DC 20010 Phone: 202-476-5000 | |
Nicole V Lang, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1145 19th St Nw, Ste 708, Washington, DC 20036 Phone: 202-955-5625 Fax: 202-955-5626 |